Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Apremilast

EU orphan designation number: EU/3/13/1180   
Active ingredient: Apremilast
Indication: Treatment of Behçet's disease
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/08/2013 Centralised Orphan - Designation EMA/OD/076/13 (2013)5279 of 05/08/2013
01/10/2013 Corrigendum (2013)6437 of 27/09/2013